Clinical trial

Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients

NCT01074918

Study summary

ClinicalTrials.gov

Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Potassium, Magnesium, Citrate Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Potassium Chloride Normalized identity: potassium chloride View linked drug · Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2009-09-01

PhasePHASE1 / PHASE2

Conditions

Pre-hypertensionunresolved

Hypertensionunresolved

Interventions

Potassium, Magnesium, CitrateDRUG

Potassium ChlorideDRUG · verified · RxNorm: potassium chloride

Sponsors & collaborators

University of Texas Southwestern Medical Centerlead sponsor

Mapped research locations

DallasTexas, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01074918 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.